AbCellera IPO Presentation Deck
EXPANSION: GMP MANUFACTURING
THE GOAL:
TARGET TO FILL-FINISH
IN ONE YEAR.
Future plans for deepening
the tech stack include:
Cell line
development
+
GMP manufacturing facility
for production of biologics
for clinical testing
AbCellera
FINANCIAL POST
AbCellera Receives $126 Million
from the Government of Canada to
Discover Solutions for COVID-19
and Build a Manufacturing Facility
for Antibody Drugs
AbCellera's world-leading drug discovery technology
identifies antibodies for potential use in drugs to treat
and prevent COVID-19
This facility, which is partly funded by a $126M grant by
the Government of Canada, will be the first in Canada
capable of going from a patient sample to manufacturing
antibodies for clinical testingView entire presentation